A Long-Term, Open-Label, Study on Schizophrenia
Clinical trial NCT01129674 · TERMINATED
Trial details
- NCT number
- NCT01129674
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-10-01
- Enrollment
- 1210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.